Clinical Trial Lifecycle Management Itrica CTLM Product Overview

The estimated cost of bringing a drug to market can range from hundreds of millions to billions of dollars, with the majority of the cost devoted to large, multi center Phase III trials. These staggering costs are driving the industry to seek ways to reduce the cost of drug development through changes in trial management, protocol design and innovations in technology.